Print

Amicus Therapeutics, Inc. (FOLD) Announces Third Quarter 2012 Financial Results & Corporate Updates  
11/6/2012 9:39:38 AM

CRANBURY, N.J., Nov. 5, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced financial results for the third quarter ended September 30, 2012. The Company also summarized recent and upcoming milestones and reiterated full-year 2012 operating expense guidance.
//-->